| Title |
Publication Date |
Price |
Relevance |
Insulin Delivery Systems Market Analysis (2008-2012)
|
August 2009 |
£925 |
100 % |
The Global Drug Delivery Market
Research Trends and Market Outlook
|
May 2006 |
£1320 |
37.5 % |
Drug Delivery Technologies
Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
|
September 2008 |
£2310 |
37 % |
Lifescan Medical Device Company Intelligence Report
|
August 2009 |
£195 |
36 % |
US Insulin Delivery Devices: Patient Acceptance Drives Demand
|
March 2003 |
£2310 |
35 % |
The World Diabetes Market, 2007-2025
An Analysis of Diabetes Drug and Insulin Market
|
March 2009 |
£235 |
33.5 % |
Leading Drug Delivery Companies and Technologies
Competitive landscape, company profiles and technological developments
|
June 2008 |
£1320 |
32 % |
The Top 100 Drug Delivery Companies Worldwide
|
January 2004 |
£570 |
31 % |
Drug Delivery Technology: Revolutionizing Diabetes Treatment
|
September 2007 |
£945 |
28.5 % |
Drug Delivery Technology
Revolutionizing Diabetes Treatment
|
September 2007 |
£945 |
28.5 % |
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2010
|
November 2009 |
£4950 |
25.9 % |
The Future of the Home Healthcare Equipment Market to 2016
Market Forecasts, Competitive Landscape and Pipeline Analysis
|
March 2010 |
£2310 |
22.05 % |
Insulin Pumps (External)
A World Market Review
|
November 2009 |
£1980 |
21.7 % |
The Future of The Diabetes Care Devices Market to 2016
The Key Demand Drivers Remain Intact
|
January 2010 |
£2310 |
21.7 % |
Argentina Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
August 2008 |
£1980 |
20.3 % |
Drug Delivery Series I-IV
|
April 2007 |
£4720 |
19.95 % |
Mexico Diabetes Care Devices Market Analysis & Forecasts to 2015
|
January 2009 |
£2310 |
19.95 % |
Drug Delivery Systems
US Market Outlook, Advances for Pharma, Biotech & Medical Devices
|
September 2006 |
£1515 |
19.95 % |
China Diabetes Care Devices Market Analysis & Forecasts to 2015
|
April 2009 |
£2310 |
19.6 % |
India Diabetes Care Devices Market Analysis and Forecasts to 2015
|
April 2009 |
£2310 |
19.25 % |
Israel Diabetes Care Devices Market Analysis & Forecasts to 2012
|
January 2009 |
£2310 |
18.9 % |
China Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
August 2008 |
£1980 |
18.55 % |
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015
|
April 2009 |
£2310 |
18.2 % |
Germany Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
August 2008 |
£1980 |
18.2 % |
Japan Diabetes Care Devices Market Analysis and Forecasts to 2015
|
May 2009 |
£2310 |
18.2 % |
India Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
September 2008 |
£1980 |
18.2 % |
Canada Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
June 2008 |
£1980 |
17.85 % |
India Diabetic/Diabetes Care Devices Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Glucose Monitoring and Insulin Delivery Devices, Equipment and Supplies
|
April 2008 |
£1980 |
17.85 % |
Brazil Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
17.85 % |
Negotiating The Emerging Biosimilars Landscape
Key Developments in The Regulatory Environment
|
February 2009 |
£2025 |
17.5 % |
Canada Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
17.5 % |
United Kingdom Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
17.15 % |
Japan Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
17.15 % |
Brazil Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1980 |
17.15 % |
Italy Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
July 2009 |
£1650 |
17.15 % |
India Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015
|
June 2009 |
£1650 |
17.15 % |
Spain Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
17.15 % |
France Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
June 2008 |
£1980 |
17.15 % |
Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
June 2008 |
£1980 |
17.15 % |
France Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
17.15 % |
Johnson & Johnson Medical Device Company Intelligence Report
|
August 2009 |
£695 |
17 % |
Australia Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
16.8 % |
U.S. Market for IV Therapy and Vein Access
|
August 2006 |
£2885 |
16.8 % |
United States Diabetes Care Devices Market Analysis & Forecasts to 2015
|
May 2009 |
£2310 |
16.8 % |
Mexico Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
November 2008 |
£1980 |
16.8 % |
Biotech Drug Delivery Systems
Key Company Intelligence & Market Outlook to 2012
|
February 2007 |
£1299 |
16.45 % |
Italy Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1980 |
16.1 % |
United States Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2015
|
March 2009 |
£1650 |
16.1 % |
Belgium Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
November 2008 |
£1980 |
16.1 % |
Innovation in Drug Delivery
The future of nanotechnology and non-invasive protein delivery
|
November 2006 |
£1495 |
16.1 % |
Australia Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1980 |
16.1 % |
Spain Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1980 |
16.1 % |
Japan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1980 |
16.1 % |
Italy Medical Equipment Market Analysis and Forecasts to 2015
|
July 2007 |
£2310 |
15.4 % |
Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to
|
November 2008 |
£1980 |
15.05 % |
Diabetes Therapies & Diagnostics: Global Markets
|
January 2008 |
£3205 |
14.7 % |
United Kingdom Medical Equipment Markets
Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012
|
March 2009 |
£1320 |
14.7 % |
Syringes (Disposable and Reusable)
Global Market Opportunities
|
November 2009 |
£1980 |
14.35 % |
United States Medical Equipment Markets Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012
|
December 2008 |
£1320 |
14 % |
United States Diabetes Care Devices Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Glucose Monitoring and Insulin Delivery Devices, Equipment and Supplies
|
April 2008 |
£1980 |
14 % |
Diabetes Drug Discoveries 2009: what the future holds
|
February 2009 |
£795 |
13.65 % |
World Diabetes Market, The
2005-2011
|
March 2006 |
£1499 |
13.3 % |
Infusion Devices: Technologies and Global Markets
|
February 2010 |
£3205 |
12.6 % |
The Future of Metabolic Disorder Therapeutics
Market Forecasts to 2015
|
December 2009 |
£2310 |
12.25 % |
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
|
February 2007 |
£1495 |
12.25 % |
Orthopedic Biomaterials, The World Market, 2nd Edition
|
September 2007 |
£2310 |
11.9 % |
Orthopedic Biomaterials, The World Market
2nd Edition
|
September 2007 |
£2310 |
11.9 % |
Disposable Syringe Markets
Trends, Industry Participants, Product Overviews and Market Drivers
|
October 2009 |
£2245 |
11.9 % |
United States Medical Equipment Markets: Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012
|
May 2008 |
£1320 |
11.55 % |
Top 10 Medical Equipment Trends in 2009
|
December 2008 |
£2310 |
11.55 % |
United States Medical Equipment Markets
Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012
|
May 2008 |
£1320 |
11.55 % |
Blood Glucose Testing and Diabetes Management
|
April 2009 |
£2245 |
10.85 % |
Global Protein Therapeutics Market, The
Market Dynamics and Pipeline Analysis
|
December 2006 |
£1980 |
10.5 % |
Intravenous Equipment
A World Market Intelligence Report
|
November 2009 |
£1980 |
10.5 % |
Biosimilars Series
Strategic Issues - Potential Remains Uncertain
|
October 2007 |
£1320 |
8.75 % |
RNAi
Technologies, Markets and Companies
|
March 2010 |
£2310 |
7.7 % |
The US Pharmaceutical Market 2009-2024
|
November 2009 |
£1499 |
6.65 % |
Cell Therapy Markets
|
July 2007 |
£2245 |
6.3 % |
Point of Care Diagnostics: Players, Products & Future Market Prospects
|
November 2009 |
£995 |
5.95 % |
Burger's Medicinal Chemistry and Drug Discovery
6 Volume Set
|
March 2003 |
£1730 |
5.95 % |
Nanobiotechnology
Applications, Markets and Companies
|
March 2010 |
£2970 |
5.25 % |
Alzheimer Disease
New Drugs, Markets and Companies
|
May 2009 |
£1850 |
4.9 % |
Cell Therapy
Technologies, Markets and Companies
|
March 2010 |
£3300 |
4.9 % |
Alzheimer's Disease
New Drugs, Markets and Companies
|
February 2010 |
£2115 |
4.55 % |
Alzheimer's disease
New Drugs, Markets and Companies
|
October 2009 |
£1980 |
4.55 % |
Alzheimer's disease
|
March 2010 |
£2115 |
4.55 % |
Alzheimer's Disease
New Drugs, Markets and Companies
|
October 2009 |
£1980 |
4.55 % |
Alzheimer's disease
New drugs, markets and companies
|
December 2008 |
£1980 |
4.2 % |
Neuroprotection
Drugs, Markets and Companies
|
March 2010 |
£2970 |
3.15 % |
